These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 11521523)
61. Histologic deterioration and more flares: the case against azathioprine plus methylprednisolone in the treatment of proliferative lupus nephritis. Chan TM Arthritis Rheum; 2007 Mar; 56(3):702-4. PubMed ID: 17328038 [No Abstract] [Full Text] [Related]
62. Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial. Grootscholten C; Snoek FJ; Bijl M; van Houwelingen HC; Derksen RH; Berden JH; J Rheumatol; 2007 Aug; 34(8):1699-707. PubMed ID: 17659757 [TBL] [Abstract][Full Text] [Related]
64. [Lupus nephritis in Senegal: study of 42 cases]. Dia D; Ka EF; Cissé M; Pouye A; Niang NM; Kane A; Dieng MT; Niang A; Ka MM; Diouf B; Ndiaye B; Moreira-Diop T Dakar Med; 2007; 52(1):23-6. PubMed ID: 19102087 [TBL] [Abstract][Full Text] [Related]
67. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis]. Haake H; Köneke J; Amann K; vom Dahl J; Janssen U Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969 [TBL] [Abstract][Full Text] [Related]
68. Summaries for patients. Kidney disease in patients with lupus who are treated with potent drugs that suppress the immune system. Ann Intern Med; 2001 Aug; 135(4):S-29. PubMed ID: 11529202 [No Abstract] [Full Text] [Related]
69. Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis. Yamaji K; Kim YJ; Tsuda H; Takasaki Y Ther Apher Dial; 2008 Aug; 12(4):298-305. PubMed ID: 18789117 [TBL] [Abstract][Full Text] [Related]
70. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis. Jedlickova H; Bohmová J; Sirotkova A Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028 [No Abstract] [Full Text] [Related]
71. Treatment and monitoring of patients with lupus nephritis. Balow JE Nephrol Dial Transplant; 1990; 5 Suppl 1():58-9. PubMed ID: 2129461 [No Abstract] [Full Text] [Related]
72. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis]. Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738 [TBL] [Abstract][Full Text] [Related]
74. [Therapy of inflammatory vascular diseases]. Lehmann H Dtsch Med Wochenschr; 1981 Mar; 106(12):370-2. PubMed ID: 7009124 [No Abstract] [Full Text] [Related]
75. The treatment of lupus nephritis: revisiting Galen. Lewis EJ Ann Intern Med; 2001 Aug; 135(4):296-8. PubMed ID: 11511144 [No Abstract] [Full Text] [Related]
76. [Preliminary report on the effects of immunosuppressive therapy with azathioprine in glomerulonephritis]. Castellani A; Romagnoli GF; Rizzo A; Borsatti A; Gambari PF; Campanacci L Minerva Nefrol; 1968; 15(4):219-35. PubMed ID: 5745810 [No Abstract] [Full Text] [Related]
78. Clinical characteristics of lupus myocarditis in Korea. Chung JW; Joe DY; Park HJ; Kim HA; Park HS; Suh CH Rheumatol Int; 2008 Jan; 28(3):275-80. PubMed ID: 17634899 [TBL] [Abstract][Full Text] [Related]